KURA vs DNA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: May 15, 2026
KURA
56.0
AI Score
VS
It's a Tie!
DNA
56.0
AI Score
Investment Advisor Scores
DNA
56score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | KURA | DNA | Winner |
|---|---|---|---|
| Revenue | 18.27M | 19.47M | DNA |
| Net Income | -73.33M | -82.59M | KURA |
| Net Margin | -401.5% | -424.1% | KURA |
| Operating Income | -78.81M | -71.37M | DNA |
| ROE | -68.0% | -18.6% | DNA |
| ROA | -11.2% | -8.0% | DNA |
| Total Assets | 652.55M | 1.03B | DNA |
| Cash | 39.08M | 143.86M | DNA |
| Current Ratio | 6.15 | 5.15 | KURA |
| Free Cash Flow | -85.98M | -48.62M | DNA |
Frequently Asked Questions
Based on our detailed analysis, KURA and DNA are evenly matched, both winning 3 key financial metrics each. This is a close call that depends on your specific investment goals.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.